https://orcid.org/0000-0001-9168-0491
Figures & data
Figure 1 Transition diagram for partitioned survival model health outcomes.
Figure 2 Estimated overall survival curve for the ESCORT trial.
Figure 3 Estimated progression survival curve for the ESCORT trial.
Table 1 Key Input Data of the Model
Table 2 Treatment-Emergent Adverse Events in Fujian Medical University Cancer Hospital
Table 3 Key Outcome Data of the Model
Figure 4 Tornado diagram for deterministic sensitivity analyses of The ICER per QALY.
Figure 5 Scatter plot of Monte Carlo sensitivity analysis.
Figure 6 Cost-effectiveness acceptability curve for camrelizumab vs docetaxel or irinotecan chemotherapy.
